SCHEMBL2552485

SCHEMBL2552485

C=C(C)C(=O)Oc1cccc2c1Cc1ccccc1-2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.51
NPC1 O15118 2/20 0.51
HTR2B P41595 3/20 0.42
HTR7 P34969 2/20 0.42
ELANE P08246 1/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPK1 P28482 1/20 0.40
PNMT P11086 1/20 0.40
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 3/20 0.39
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTR2C P28335 2/20 0.38
CYP1A2 P05177 1/20 0.38
ADRA2A P08913 1/20 0.38
MAOA P21397 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
ALOX12 P18054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12701336 0.93 RAB9A (0.50) RAB9ANPC1HTR2BHTR7ELANE
SCHEMBL29112976 0.87 RAB9A (0.46) RAB9ANPC1HTR2BHTR7KDM4E
SCHEMBL2131214 0.86 RAB9A (0.55) RAB9ANPC1HTR2BHTR7KDM4E
SCHEMBL1151461 0.86 RAB9A (0.49) RAB9ANPC1HTR2BHTR7KDM4E
SCHEMBL18499917 0.85 RAB9A (0.44) RAB9ANPC1HTR2BHTR7KDM4E
SCHEMBL30695173 0.85 RAB9A (0.47) RAB9ANPC1HTR2BHTR7KDM4E
SCHEMBL1315278 0.83 ATM (0.49) RAB9ANPC1HTR2BHTR7KDM4E
SCHEMBL8840922 0.83 RAB9A (0.54) RAB9ANPC1HTR2BHTR7KDM4E
SCHEMBL28108164 0.82 ELANE (0.48) RAB9ANPC1HTR2BHTR7ELANE
SCHEMBL20917777 0.81 RAB9A (0.49) RAB9ANPC1HTR2BHTR7KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112980549-B High viscosity index comb polymer viscosity modifiers and methods of using the same to alter lubricant viscosity 英菲诺姆国际有限公司 2023-12-15 CN claimed
EP-3839018-B1 HIGH VISCOSITY INDEX COMB POLYMER VISCOSITY MODIFIERS AND METHODS OF MODIFYING LUBRICANT VISCOSITY USING SAME INFINEUM INT LTD (GB) 2023-10-18 EP claimed
US-11365273-B2 High viscosity index comb polymer viscosity modifiers and methods of modifying lubricant viscosity using same INFINEUM INTERNATIONAL LIMITED (GB) 2022-06-21 US claimed
EP-3877454-B1 NANOSTRUCTURED OPTICAL FILMS AND INTERMEDIATES 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-04-29 EP disclosed
US-20260084388-A1 NANOSTRUCTURED OPTICAL FILMS AND INTERMEDIATES 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-03-26 US disclosed
US-20260079286-A1 Structured Film and Optical Article Including Structured Film 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-03-19 US disclosed
US-12504567-B2 Structured film and optical article including structured film 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-12-23 US disclosed
EP-4267708-B1 THERMALLY RESPONSIVE BRUSH POLYMERS HAVING A COPOLYMER BACKBONE AND COPOLYMER ARMS INFINEUM INT LTD (GB) 2025-07-02 EP disclosed
US-12343953-B2 Nanostructured optical films and intermediates 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-07-01 US disclosed
US-12281203-B2 Thermally responsive brush polymers having a copolymer backbone and copolymer arms INFINEUM INTERNATIONAL LIMITED (GB) 2025-04-22 US disclosed
US-12263656-B2 Materials and methods for forming nano-structures on substrates 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-04-01 US disclosed
US-8450042-B2 Positive resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-05-28 US disclosed
US-20130090031-A1 COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF FERRANIA TECHNOLOGIES S.P.A. (IT) 2013-04-11 US disclosed
EP-2556113-A1 COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF Ferrania Technologies S.p.A. (IT) 2013-02-13 EP disclosed
EP-2556113-A1 COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF Ferrania Technologies S.p.A. (IT) 2013-02-13 EP disclosed
US-8211618-B2 Positive resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-07-03 US disclosed
WO-2011124522-A1 COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF FERRANIA TECHNOLOGIES S.P.A. (IT) 2011-10-13 WO disclosed
WO-2011124522-A1 COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF FERRANIA TECHNOLOGIES S.P.A. (IT) 2011-10-13 WO disclosed
US-20100227273-A1 POSITIVE RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-09-09 US disclosed
US-20100227274-A1 POSITIVE RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260079286-A1 Structured Film and Optical Article Including Structured Film CDH1, ICAM1, SAAL1 RAB9A 1572/4885NPC1 3890/4885HTR2B 2153/4885
US-20260084388-A1 NANOSTRUCTURED OPTICAL FILMS AND INTERMEDIATES TNFRSF1A, MTX2, MTX1 RAB9A 1644/4885NPC1 1906/4885HTR2B 2066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.